Mankind Pharma Limited (MANKIND)

2,586.45

INR
-9.70(-0.37%)
As of December 6, 2024 10:00:00 AM

Mankind Pharma Limited Share Price Information

24 hour Low and High

Low: 2583.05
High: 2633.4

All time High

9434.37

Price Change 1h

+₹-9.70 +-0.37%

Price Change 1d

+₹-9.70 +-0.37%

Price Change 1w

+₹-11.20 +-0.43%

Mankind Pharma Limited Market Information

Exchange

NSE

Market Cap

106884.18 Cr

About Mankind Pharma Limited Share

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

19540

CEO

Mr. Sheetal Arora

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Mankind Pharma Ltd rises for third consecutive session
  • Mankind Pharma pledges 39.68% stake in Bharat Serums to secure ₹5,000 crore NCDs | Stock Market News
  • Here's Why Mankind Pharma (NSE:MANKIND) Can Manage Its Debt Responsibly
  • Mankind Pharma shares gain over 6% as profit jumps nearly 30% in Q2
  • Multibagger stock: Mankind Pharma hits fresh highs after Q2 results; is more steam left?

FAQs

Mankind Pharma Limited (MANKIND)

2,586.45

INR
-9.70(-0.37%)
As of December 6, 2024 10:00:00 AM

Mankind Pharma Limited Share Price Information

24 hour Low and High

Low: 2583.05
High: 2633.4

All time High

9434.37

Price Change 1h

+₹-9.70 +-0.37%

Price Change 1d

+₹-9.70 +-0.37%

Price Change 1w

+₹-11.20 +-0.43%

Mankind Pharma Limited Market Information

Exchange

NSE

Market Cap

106884.18 Cr

About Mankind Pharma Limited Share

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

19540

CEO

Mr. Sheetal Arora

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Mankind Pharma Ltd rises for third consecutive session
  • Mankind Pharma pledges 39.68% stake in Bharat Serums to secure ₹5,000 crore NCDs | Stock Market News
  • Here's Why Mankind Pharma (NSE:MANKIND) Can Manage Its Debt Responsibly
  • Mankind Pharma shares gain over 6% as profit jumps nearly 30% in Q2
  • Multibagger stock: Mankind Pharma hits fresh highs after Q2 results; is more steam left?

FAQs